综合性转录组定型将端粒功能障碍与cGAS-STING激活联系在小鼠和人类心力衰竭的特征中
Moritz Brandt1,2,3,4,5, Sana'a Khraisat1,2,3, Qi Luo1,2,3
1Department of Cardiology, University Medical Center Mainz, Germany.
Cardiovascular research
|January 22, 2026
概括
心脏细胞中的端粒缩短通过激活p53和影响线粒体,导致心力衰竭. 这项研究揭示了涉及心脏功能障碍的更广泛的炎症和神经道.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 心肌细胞端粒缩短是心力衰竭的一个标志.
- 在小鼠中,端粒酶缺乏导致心肌功能障碍,p53激活和线粒体抑制.
研究的目的:
- 为了调查端粒酶缺乏小鼠的心脏功能障碍是否源于内在的心肌效应或全身端粒缩短后果.
- 为了识别受心肌细胞端粒缩短影响的更广泛的转录程序.
- 探索这些发现对人类心力衰竭的临床相关性.
主要方法:
- 产生了连续几代端粒酶缺乏的小鼠 (mTRG5).
- 进行了全面的心血管表型鉴定,并评估了线粒体功能.
- 进行了转录和调节分析,将mTRG5小鼠与神经瘤诱导高血压心力衰竭 (ANS) 模型进行比较.
- 分析了缺少三主要外核酶1 (TREX1) 的小鼠的心肌样本,以研究I型干扰素信号传递和cGAS-STING通路激活.
主要成果:
- 在mTRG5小鼠中,端粒缩短导致心脏功能障碍,与p53-线粒体轴,神经道激活,衰老和炎症 (I型干扰素信号) 相关.
- 端粒功能障碍和p53激活被确定为mTRG5小鼠的主要驱动因素,而ANS小鼠中主导的神经幽默因子.
- 在mTRG5和ANS小鼠中发现了cGAS-STING通路激活的证据,将其与端粒缩短和心力衰竭联系起来.
结论:
- mTRG5小鼠的转录特征与人类和小鼠扩张性和缺血性心肌病症有显著的重叠.
- 研究结果表明,端粒缩短是心力衰竭病原发生的关键上游驱动因素.
- 这项研究强调了端粒缩短和相关炎症途径在心力衰竭中的临床相关性.
相关概念视频
02:41Telomeres and Telomerase
26.9K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
26.9K
01:29Heart Failure II: Pathophysiology
798
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
798
01:17Pathophysiology of Heart Failure
3.1K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.1K
01:27Heart Failure I: Introduction
737
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
737
01:22Heart Failure VI: Adjunct Therapies
280
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
280
01:22Heart Failure Drugs: Diuretics
830
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
830